The purification challenge behind engineered antibody drugs for cancer

This article explores the complex science and engineering behind purifying pharmaceutical molecules at industrial scale, focusing on bispecific antibodies — engineered molecules that can target cancer cells and immune cells simultaneously. It highlights the challenges of manufact